Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
53.68%
0%
53.68%
6 Months
53.9%
0%
53.9%
1 Year
20.11%
0%
20.11%
2 Years
36.42%
0%
36.42%
3 Years
4.71%
0%
4.71%
4 Years
55.97%
0%
55.97%
5 Years
-12.7%
0%
-12.7%
Viemed Healthcare, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.63%
EBIT Growth (5y)
0.13%
EBIT to Interest (avg)
17.50
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
1.55
Tax Ratio
28.83%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.50%
ROE (avg)
15.81%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.90
EV to EBIT
15.11
EV to EBITDA
5.85
EV to Capital Employed
2.01
EV to Sales
1.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.29%
ROE (Latest)
10.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 27 Schemes (3.48%)
Foreign Institutions
Held by 145 Foreign Institutions (56.25%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQ
Dec'23
Sep'23
Change(%)
Net Sales
69.10
66.30
4.22%
Operating Profit (PBDIT) excl Other Income
15.80
14.30
10.49%
Interest
0.30
0.30
Exceptional Items
-0.00
0.10
-100.00%
Consolidate Net Profit
4.70
3.90
20.51%
Operating Profit Margin (Excl OI)
110.80%
94.30%
1.65%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2023 is 4.22% vs 13.92% in Sep 2023
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2023 is 20.51% vs 25.81% in Sep 2023
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
247.00
180.70
36.69%
Operating Profit (PBDIT) excl Other Income
50.50
31.50
60.32%
Interest
0.60
0.30
100.00%
Exceptional Items
-0.10
1.20
-108.33%
Consolidate Net Profit
13.80
8.10
70.37%
Operating Profit Margin (Excl OI)
84.80%
61.90%
2.29%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 36.69% vs 23.09% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 70.37% vs -28.95% in Dec 2022






